A Phase II, Pharmacokinetic, Randomized, Double-Masked, Controlled, Dose Comparison Study of Cand5 for Intraviteral Injection for the Treatment of Diabetic Macular Edema

Trial Profile

A Phase II, Pharmacokinetic, Randomized, Double-Masked, Controlled, Dose Comparison Study of Cand5 for Intraviteral Injection for the Treatment of Diabetic Macular Edema

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2014

At a glance

  • Drugs Bevasiranib (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Sponsors OPKO Health
  • Most Recent Events

    • 25 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top